Epstein Files Full PDF

CLICK HERE
Technopedia Center
PMB University Brochure
Faculty of Engineering and Computer Science
S1 Informatics S1 Information Systems S1 Information Technology S1 Computer Engineering S1 Electrical Engineering S1 Civil Engineering

faculty of Economics and Business
S1 Management S1 Accountancy

Faculty of Letters and Educational Sciences
S1 English literature S1 English language education S1 Mathematics education S1 Sports Education
teknopedia

  • Registerasi
  • Brosur UTI
  • Kip Scholarship Information
  • Performance
Flag Counter
  1. World Encyclopedia
  2. KLF13 - Wikipedia
KLF13 - Wikipedia
From Wikipedia, the free encyclopedia
Protein found in humans
KLF13
Identifiers
AliasesKLF13, BTEB3, FKLF2, NSLP1, RFLAT-1, RFLAT1, Kruppel-like factor 13, Kruppel like factor 13
External IDsOMIM: 605328; MGI: 1354948; HomoloGene: 32288; GeneCards: KLF13; OMA:KLF13 - orthologs
Gene location (Human)
Chromosome 15 (human)
Chr.Chromosome 15 (human)[1]
Chromosome 15 (human)
Genomic location for KLF13
Genomic location for KLF13
Band15q13.3Start31,326,835 bp[1]
End31,435,665 bp[1]
Gene location (Mouse)
Chromosome 7 (mouse)
Chr.Chromosome 7 (mouse)[2]
Chromosome 7 (mouse)
Genomic location for KLF13
Genomic location for KLF13
Band7|7 CStart63,536,099 bp[2]
End63,588,663 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • right hemisphere of cerebellum

  • granulocyte

  • right lung

  • mucosa of transverse colon

  • right frontal lobe

  • left lobe of thyroid gland

  • body of pancreas

  • right lobe of thyroid gland

  • monocyte

  • ganglionic eminence
Top expressed in
  • Rostral migratory stream

  • molar

  • thymus

  • granulocyte

  • blood

  • ankle

  • hair follicle

  • mesenteric lymph nodes

  • external carotid artery

  • Region I of hippocampus proper
More reference expression data
BioGPS
More reference expression data
Gene ontology
Molecular function
  • RNA polymerase II cis-regulatory region sequence-specific DNA binding
  • DNA binding
  • DNA-binding transcription activator activity, RNA polymerase II-specific
  • protein binding
  • metal ion binding
  • nucleic acid binding
  • DNA-binding transcription factor activity, RNA polymerase II-specific
Cellular component
  • nucleus
Biological process
  • regulation of transcription, DNA-templated
  • transcription by RNA polymerase II
  • positive regulation of transcription by RNA polymerase II
  • negative regulation of cell population proliferation
  • negative regulation of erythrocyte differentiation
  • transcription, DNA-templated
  • regulation of transcription by RNA polymerase II
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

51621

50794

Ensembl

ENSG00000169926
ENSG00000275746

ENSMUSG00000052040

UniProt

Q9Y2Y9

Q9JJZ6

RefSeq (mRNA)

NM_001302461
NM_015995

NM_021366

RefSeq (protein)

NP_001289390
NP_057079

NP_067341

Location (UCSC)Chr 15: 31.33 – 31.44 MbChr 7: 63.54 – 63.59 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Kruppel-like factor 13, also known as KLF13, is a protein that in humans is encoded by the KLF13 gene.[5][6][7]

There is some evidence for KLF13 having a role in obesity. A methylation site, cg07814318, within the first intron of KLF13 has been associated with obesity and orexigenic processes.[8] Ghrelin levels also positively correlated with methylation levels of cg07814318.[8] Moreover, expression levels of KLF13 were decreased and increased in the brains of starved and obese mice, respectively.[8]

Function

[edit]

KLF13 belongs to a family of transcription factors that contain 3 classical zinc finger DNA-binding domains consisting of a zinc atom tetrahedrally coordinated by 2 cysteines and 2 histidines (C2H2 motif). These transcription factors bind to GC-rich sequences and related GT and CACCC boxes.[5][9]

KLF13 was first described as the RANTES factor of late activated T lymphocytes (RFLAT)-1.[7] It regulates the expression of the chemokine RANTES in T lymphocytes. It functions as a lynchpin, inducing a large enhancesome. KLF13 knock-out mice show a defect in lymphocyte survival as KLF13 is a regulator of Bcl-xL expression.[7][10][11][12][13][14][15]

Interactions

[edit]

KLF13 has been shown to interact with CREB-binding protein,[16] Heat shock protein 47[16] and PCAF.[16]

See also

[edit]
  • Kruppel-like factors

References

[edit]
  1. ^ a b c ENSG00000275746 GRCh38: Ensembl release 89: ENSG00000169926, ENSG00000275746 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000052040 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: KLF13 Kruppel-like factor 13".
  6. ^ Cook T, Gebelein B, Urrutia R (Jun 1999). "Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors". Annals of the New York Academy of Sciences. 880 (1 CELL AND MOLE): 94–102. Bibcode:1999NYASA.880...94C. doi:10.1111/j.1749-6632.1999.tb09513.x. PMID 10415854. S2CID 7618847.
  7. ^ a b c Song A, Chen YF, Thamatrakoln K, Storm TA, Krensky AM (Jan 1999). "RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes". Immunity. 10 (1): 93–103. doi:10.1016/S1074-7613(00)80010-2. PMID 10023774.
  8. ^ a b c Wiemerslage L, Islam R, van der Kamp C, Cao H, Olivo G, Ence-Eriksson F, Castillo S, Larsen AL, Bandstein M, Dahlberg LS, Perland E, Gustavsson V, Nilsson J, Vogel H, Schürmann A, Larsson EM, Rask-Andersen M, Benedict C, Schiöth HB (14 Feb 2017). "A DNA methylation site within the KLF13 gene is associated with orexigenic processes based on neural responses and ghrelin levels". Int J Obes (Lond). 43 (6): 990–994. doi:10.1038/ijo.2017.43. PMID 28194012. S2CID 52835570.
  9. ^ Scohy S, Gabant P, Van Reeth T, Hertveldt V, Drèze PL, Van Vooren P, Rivière M, Szpirer J, Szpirer C (Nov 2000). "Identification of KLF13 and KLF14 (SP6), novel members of the SP/XKLF transcription factor family". Genomics. 70 (1): 93–101. doi:10.1006/geno.2000.6362. PMID 11087666.
  10. ^ Song A, Nikolcheva T, Krensky AM (Oct 2000). "Transcriptional regulation of RANTES expression in T lymphocytes". Immunological Reviews. 177 (1): 236–45. doi:10.1034/j.1600-065X.2000.17610.x. PMID 11138780. S2CID 30184294.
  11. ^ Nikolcheva T, Pyronnet S, Chou SY, Sonenberg N, Song A, Clayberger C, Krensky AM (Jul 2002). "A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes". The Journal of Clinical Investigation. 110 (1): 119–26. doi:10.1172/JCI15336. PMC 151028. PMID 12093895.
  12. ^ Song A, Patel A, Thamatrakoln K, Liu C, Feng D, Clayberger C, Krensky AM (Aug 2002). "Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like transcription factor of activated T lymphocytes". The Journal of Biological Chemistry. 277 (33): 30055–65. doi:10.1074/jbc.M204278200. PMID 12050170.
  13. ^ Zhou M, McPherson L, Feng D, Song A, Dong C, Lyu SC, Zhou L, Shi X, Ahn YT, Wang D, Clayberger C, Krensky AM (May 2007). "Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo". Journal of Immunology. 178 (9): 5496–504. doi:10.4049/jimmunol.178.9.5496. PMC 2664650. PMID 17442931.
  14. ^ Huang B, Ahn YT, McPherson L, Clayberger C, Krensky AM (Jun 2007). "Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription". Journal of Immunology. 178 (11): 7081–7. doi:10.4049/jimmunol.178.11.7081. PMC 2674583. PMID 17513757.
  15. ^ Ahn YT, Huang B, McPherson L, Clayberger C, Krensky AM (Jan 2007). "Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes". Molecular and Cellular Biology. 27 (1): 253–66. doi:10.1128/MCB.01071-06. PMC 1800668. PMID 17074812.
  16. ^ a b c Song CZ, Keller K, Murata K, Asano H, Stamatoyannopoulos G (Mar 2002). "Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2". The Journal of Biological Chemistry. 277 (9): 7029–36. doi:10.1074/jbc.M108826200. PMC 2808425. PMID 11748222.

Further reading

[edit]
  • Cook T, Gebelein B, Urrutia R (Jun 1999). "Sp1 and its likes: biochemical and functional predictions for a growing family of zinc finger transcription factors". Annals of the New York Academy of Sciences. 880 (1 CELL AND MOLE): 94–102. Bibcode:1999NYASA.880...94C. doi:10.1111/j.1749-6632.1999.tb09513.x. PMID 10415854. S2CID 7618847.
  • Song A, Chen YF, Thamatrakoln K, Storm TA, Krensky AM (Jan 1999). "RFLAT-1: a new zinc finger transcription factor that activates RANTES gene expression in T lymphocytes". Immunity. 10 (1): 93–103. doi:10.1016/S1074-7613(00)80010-2. PMID 10023774.
  • Asano H, Li XS, Stamatoyannopoulos G (Jun 2000). "FKLF-2: a novel Krüppel-like transcriptional factor that activates globin and other erythroid lineage genes". Blood. 95 (11): 3578–84. doi:10.1182/blood.V95.11.3578. PMID 10828046.
  • Scohy S, Gabant P, Van Reeth T, Hertveldt V, Drèze PL, Van Vooren P, Rivière M, Szpirer J, Szpirer C (Nov 2000). "Identification of KLF13 and KLF14 (SP6), novel members of the SP/XKLF transcription factor family". Genomics. 70 (1): 93–101. doi:10.1006/geno.2000.6362. PMID 11087666.
  • Kaczynski J, Zhang JS, Ellenrieder V, Conley A, Duenes T, Kester H, van Der Burg B, Urrutia R (Sep 2001). "The Sp1-like protein BTEB3 inhibits transcription via the basic transcription element box by interacting with mSin3A and HDAC-1 co-repressors and competing with Sp1". The Journal of Biological Chemistry. 276 (39): 36749–56. doi:10.1074/jbc.M105831200. PMID 11477107.
  • Song CZ, Keller K, Murata K, Asano H, Stamatoyannopoulos G (Mar 2002). "Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2". The Journal of Biological Chemistry. 277 (9): 7029–36. doi:10.1074/jbc.M108826200. PMC 2808425. PMID 11748222.
  • Kaczynski JA, Conley AA, Fernandez Zapico M, Delgado SM, Zhang JS, Urrutia R (Sep 2002). "Functional analysis of basic transcription element (BTE)-binding protein (BTEB) 3 and BTEB4, a novel Sp1-like protein, reveals a subfamily of transcriptional repressors for the BTE site of the cytochrome P4501A1 gene promoter". The Biochemical Journal. 366 (Pt 3): 873–82. doi:10.1042/BJ20020388. PMC 1222816. PMID 12036432.
  • Song A, Patel A, Thamatrakoln K, Liu C, Feng D, Clayberger C, Krensky AM (Aug 2002). "Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like transcription factor of activated T lymphocytes". The Journal of Biological Chemistry. 277 (33): 30055–65. doi:10.1074/jbc.M204278200. PMID 12050170.
  • Nikolcheva T, Pyronnet S, Chou SY, Sonenberg N, Song A, Clayberger C, Krensky AM (Jul 2002). "A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes". The Journal of Clinical Investigation. 110 (1): 119–26. doi:10.1172/JCI15336. PMC 151028. PMID 12093895.
  • Mitsuma A, Asano H, Kinoshita T, Murate T, Saito H, Stamatoyannopoulos G, Naoe T (Feb 2005). "Transcriptional regulation of FKLF-2 (KLF13) gene in erythroid cells". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1727 (2): 125–33. doi:10.1016/j.bbaexp.2004.12.007. PMC 2808416. PMID 15716005.
  • Zhang P, Basu P, Redmond LC, Morris PE, Rupon JW, Ginder GD, Lloyd JA (2006). "A functional screen for Krüppel-like factors that regulate the human gamma-globin gene through the CACCC promoter element". Blood Cells, Molecules & Diseases. 35 (2): 227–35. doi:10.1016/j.bcmd.2005.04.009. PMID 16023392.
  • Ahn YT, Huang B, McPherson L, Clayberger C, Krensky AM (Jan 2007). "Dynamic interplay of transcriptional machinery and chromatin regulates "late" expression of the chemokine RANTES in T lymphocytes". Molecular and Cellular Biology. 27 (1): 253–66. doi:10.1128/MCB.01071-06. PMC 1800668. PMID 17074812.
  • Huang B, Ahn YT, McPherson L, Clayberger C, Krensky AM (Jun 2007). "Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription". Journal of Immunology. 178 (11): 7081–7. doi:10.4049/jimmunol.178.11.7081. PMC 2674583. PMID 17513757.

External links

[edit]
  • KLF13+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

  • v
  • t
  • e
Transcription factors and intracellular receptors
(1) Basic domains
(1.1) Basic leucine zipper (bZIP)
  • Activating transcription factor
    • AATF
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • AP-1
    • c-Fos
    • FOSB
    • FOSL1
    • FOSL2
    • JDP2
    • c-Jun
    • JUNB
    • JunD
  • BACH
    • 1
    • 2
  • BATF
  • BLZF1
  • C/EBP
    • α
    • β
    • γ
    • δ
    • ε
    • ζ
  • CREB
    • 1
    • 3
    • L1
  • CREM
  • DBP
  • DDIT3
  • GABPA
  • GCN4
  • HLF
  • MAF
    • B
    • sMaf
      • F
      • G
      • K
  • NFE
    • 2
    • L1
    • L2
    • L3
  • NFIL3
  • NRL
  • NRF
    • 1
    • 2
    • 3
  • XBP1
(1.2) Basic helix-loop-helix (bHLH)
Group A
  • AS-C
    • ASCL1
    • ASCL2
  • ATOH1
  • HAND
    • 1
    • 2
  • MESP2
  • Myogenic regulatory factors
    • MyoD
    • Myogenin
    • MYF5
    • MYF6
  • NeuroD
    • 1
    • 2
  • Neurogenins
    • 1
    • 2
    • 3
  • OLIG
    • 1
    • 2
  • Paraxis
    • TCF15
    • Scleraxis
  • SLC
    • LYL1
    • TAL
      • 1
      • 2
  • Twist
Group B
  • FIGLA
  • Myc
    • c-Myc
    • l-Myc
    • n-Myc
  • MXD4
  • TCF4
Group C
bHLH-PAS
  • AhR
  • AHRR
  • ARNT
    • ARNTL
    • ARNTL2
  • CLOCK
  • HIF
    • 1A
    • EPAS1
    • 3A
  • NPAS
    • 1
    • 2
    • 3
  • PER
    • 1
    • 2
    • 3
    • Period
  • SIM
    • 1
    • 2
Group D
  • DEC
    • 1
    • 2
  • BHLHA9
  • Pho4
  • ID
    • 1
    • 2
    • 3
    • 4
Group E
  • HES
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
  • HEY
    • 1
    • 2
    • L
Group F
bHLH-COE
  • EBF1
(1.3) bHLH-ZIP
  • AP-4
  • MAX
    • MXD1
    • MXD3
  • MITF
  • MNT
  • MLX
  • MLXIPL
  • MXI1
  • Myc
  • SREBP
    • 1
    • 2
  • USF1
(1.4) NF-1
  • NFI
    • A
    • B
    • C
    • X
  • SMAD
    • R-SMAD
      • 1
      • 2
      • 3
      • 5
      • 9
    • I-SMAD
      • 6
      • 7
    • 4)
(1.5) RF-X
  • RFX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • ANK
(1.6) Basic helix-span-helix (bHSH)
  • AP-2
    • α
    • β
    • γ
    • δ
    • ε
(2) Zinc finger DNA-binding domains
(2.1) Nuclear receptor (Cys4)
subfamily 1
  • Thyroid hormone
    • α
    • β
  • CAR
  • FXR
  • LXR
    • α
    • β
  • PPAR
    • α
    • β/δ
    • γ
  • PXR
  • RAR
    • α
    • β
    • γ
  • ROR
    • α
    • β
    • γ
  • Rev-ErbA
    • α
    • β
  • VDR
subfamily 2
  • COUP-TF
    • (I
    • II
  • Ear-2
  • HNF4
    • α
    • γ
  • PNR
  • RXR
    • α
    • β
    • γ
  • Testicular receptor
    • 2
    • 4
  • TLX
subfamily 3
  • Steroid hormone
    • Androgen
    • Estrogen
      • α
      • β
    • Glucocorticoid
    • Mineralocorticoid
    • Progesterone
  • Estrogen related
    • α
    • β
    • γ
subfamily 4
  • NUR
    • NGFIB
    • NOR1
    • NURR1
subfamily 5
  • LRH-1
  • SF1
subfamily 6
  • GCNF
subfamily 0
  • DAX1
  • SHP
(2.2) Other Cys4
  • GATA
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • MTA
    • 1
    • 2
    • 3
  • TRPS1
(2.3) Cys2His2
  • General transcription factors
    • TFIIA
    • TFIIB
    • TFIID
    • TFIIE
      • 1
      • 2
    • TFIIF
    • 1
    • 2
      • TFIIH
      • 1
      • 2
      • 4
      • 2I
      • 3A
      • 3C1
      • 3C2
  • ATBF1
  • BCL
    • 6
    • 11A
    • 11B
  • CTCF
  • E4F1
  • EGR
    • 1
    • 2
    • 3
    • 4
  • ERV3
  • GFI1
  • GLI family
    • 1
    • 2
    • 3
    • REST
    • S1
    • S2
    • YY1
  • HIC
    • 1
    • 2
  • HIVEP
    • 1
    • 2
    • 3
  • IKZF
    • 1
    • 2
    • 3
  • ILF
    • 2
    • 3
  • Sp/KLF family
    • KLF
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • 7
      • 8
      • 9
      • 10
      • 11
      • 12
      • 13
      • 14
      • 15
      • 17
    • SP
      • 1
      • 2
      • 4
      • 7
      • 8
  • MTF1
  • MYT1
  • OSR1
  • PRDM9
  • SALL
    • 1
    • 2
    • 3
    • 4
  • TSHZ3
  • WT1
  • Zbtb7
    • 7A
    • 7B
  • ZBTB
    • 11
    • 16
    • 17
    • 20
    • 21
    • 32
    • 33
    • 40
  • zinc finger
    • 3
    • 7
    • 9
    • 10
    • 19
    • 22
    • 24
    • 33B
    • 34
    • 35
    • 41
    • 43
    • 44
    • 51
    • 74
    • 143
    • 146
    • 148
    • 165
    • 202
    • 217
    • 219
    • 238
    • 239
    • 259
    • 267
    • 268
    • 281
    • 300
    • 318
    • 330
    • 346
    • 350
    • 365
    • 366
    • 384
    • 423
    • 451
    • 452
    • 471
    • 593
    • 638
    • 644
    • 649
    • 655
    • 804A
(2.4) Cys6
  • HIVEP1
(2.5) Alternating composition
  • AIRE
  • DIDO1
  • GRLF1
  • ING
    • 1
    • 2
    • 4
  • JARID
    • 1A
    • 1B
    • 1C
    • 1D
    • 2
  • JMJD1B
(2.6) WRKY
  • WRKY
(3) Helix-turn-helix domains
(3.1) Homeodomain
Antennapedia
ANTP class
protoHOX
Hox-like
  • ParaHox
    • Gsx
      • 1
      • 2
    • Xlox
      • PDX1
    • Cdx
      • 1
      • 2
      • 4
  • extended Hox: Evx1
  • Evx2
  • MEOX1
  • MEOX2
  • Homeobox
    • A1
    • A2
    • A3
    • A4
    • A5
    • A7
    • A9
    • A10
    • A11
    • A13
    • B1
    • B2
    • B3
    • B4
    • B5
    • B6
    • B7
    • B8
    • B9
    • B13
    • C4
    • C5
    • C6
    • C8
    • C9
    • C10
    • C11
    • C12
    • C13
    • D1
    • D3
    • D4
    • D8
    • D9
    • D10
    • D11
    • D12
    • D13
  • GBX1
  • GBX2
  • MNX1
metaHOX
NK-like
  • BARHL1
  • BARHL2
  • BARX1
  • BARX2
  • BSX
  • DBX
    • 1
    • 2
  • DLX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
  • EMX
    • 1
    • 2
  • EN
    • 1
    • 2
  • HHEX
  • HLX
  • LBX1
  • LBX2
  • MSX
    • 1
    • 2
  • NANOG
  • NKX
    • 2-1
    • 2-2
    • 2-3
    • 2-5
    • 3-1
    • 3-2
    • HMX1
    • HMX2
    • HMX3
    • 6-1
    • 6-2
  • NOTO
  • TLX1
  • TLX2
  • TLX3
  • VAX1
  • VAX2
other
  • ARX
  • CRX
  • CUTL1
  • FHL
    • 1
    • 2
    • 3
  • HESX1
  • HOPX
  • LMX
    • 1A
    • 1B
  • NOBOX
  • TALE
    • IRX
      • 1
      • 2
      • 3
      • 4
      • 5
      • 6
      • MKX
    • MEIS
      • 1
      • 2
    • PBX
      • 1
      • 2
      • 3
    • PKNOX
      • 1
      • 2
    • SIX
      • 1
      • 2
      • 3
      • 4
      • 5
  • PHF
    • 1
    • 3
    • 6
    • 8
    • 10
    • 16
    • 17
    • 20
    • 21A
  • POU domain
    • PIT-1
    • BRN-3: A
    • B
    • C
    • Octamer transcription factor: 1
    • 2
    • 3/4
    • 6
    • 7
    • 11
  • SATB2
  • ZEB
    • 1
    • 2
(3.2) Paired box
  • PAX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
  • PRRX
    • 1
    • 2
  • PROP1
  • PHOX
    • 2A
    • 2B
  • RAX
  • SHOX
  • SHOX2
  • VSX1
  • VSX2
  • Bicoid
    • GSC
    • BICD2
    • OTX
      • 1
      • 2
    • PITX
      • 1
      • 2
      • 3
(3.3) Fork head / winged helix
  • E2F
    • 1
    • 2
    • 3
    • 4
    • 5
  • FOX proteins
    • A1
    • A2
    • A3
    • B1
    • B2
    • C1
    • C2
    • D1
    • D2
    • D3
    • D4
    • D4L1
    • D4L3
    • D4L4
    • D4L5
    • D4L6
    • E1
    • E3
    • F1
    • F2
    • G1
    • H1
    • I1
    • I2
    • I3
    • J1
    • J2
    • J3
    • K1
    • K2
    • L1
    • L2
    • M1
    • N1
    • N2
    • N3
    • N4
    • O1
    • O3
    • O4
    • O6
    • P1
    • P2
    • P3
    • P4
    • Q1
    • R1
    • R2
    • S1
(3.4) Heat shock factors
  • HSF
    • 1
    • 2
    • 4
(3.5) Tryptophan clusters
  • ELF
    • 2
    • 4
    • 5
  • EHF
  • ELK
    • 1
    • 3
    • 4
  • ERF
  • ETS
    • 1
    • 2
    • ERG
    • SPIB
  • ETV
    • 1
    • 4
    • 5
    • 6
  • FLI1
  • Interferon regulatory factors
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
  • MYB
  • MYBL2
(3.6) TEA domain
  • transcriptional enhancer factor
    • 1
    • 2
    • 3
    • 4
(4) β-Scaffold factors with minor groove contacts
(4.1) Rel homology region
  • NF-κB
    • NFKB1
    • NFKB2
    • REL
    • RELA
    • RELB
  • NFAT
    • C1
    • C2
    • C3
    • C4
    • 5
(4.2) STAT
  • STAT
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
(4.3) p53-like
  • p53 p63 p73 family
    • p53
    • TP63
    • p73
  • TBX
    • 1
    • 2
    • 3
    • 5
    • 19
    • 21
    • 22
    • TBR1
    • TBR2
    • TFT
  • MYRF
(4.4) MADS box
  • Mef2
    • A
    • B
    • C
    • D
  • SRF
(4.6) TATA-binding proteins
  • TBP
  • TBPL1
(4.7) High-mobility group
  • BBX
  • HMGB
    • 1
    • 2
    • 3
    • 4
  • HMGN
    • 1
    • 2
    • 3
    • 4
  • HNF
    • 1A
    • 1B
  • SOX
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    • 17
    • 18
    • 21
  • SRY
  • SSRP1
  • TCF/LEF
    • TCF
      • 1
      • 3
      • 4
    • LEF1
  • TOX
    • 1
    • 2
    • 3
    • 4
(4.9) Grainyhead
  • TFCP2
(4.10) Cold-shock domain
  • CSDA
  • YBX1
(4.11) Runt
  • CBF
    • CBFA2T2
    • CBFA2T3
    • RUNX1
    • RUNX2
    • RUNX3
    • RUNX1T1
(0) Other transcription factors
(0.2) HMGI(Y)
  • HMGA
    • 1
    • 2
  • HBP1
(0.3) Pocket domain
  • Rb
  • RBL1
  • RBL2
(0.5) AP-2/EREBP-related factors
  • Apetala 2
  • EREBP
  • B3
(0.6) Miscellaneous
  • ARID
    • 1A
    • 1B
    • 2
    • 3A
    • 3B
    • 4A
  • CAP
  • IFI
    • 16
    • 35
  • MLL
    • 2
    • 3
    • T1
  • MNDA
  • NFY
    • A
    • B
    • C
  • Rho/Sigma
see also transcription factor/coregulator deficiencies
Retrieved from "https://teknopedia.ac.id/w/index.php?title=KLF13&oldid=1301324808"
Categories:
  • Genes on human chromosome 15
  • Transcription factors
Hidden categories:
  • Articles with short description
  • Short description is different from Wikidata
  • Wikipedia articles incorporating text from the United States National Library of Medicine

  • indonesia
  • Polski
  • العربية
  • Deutsch
  • English
  • Español
  • Français
  • Italiano
  • مصرى
  • Nederlands
  • 日本語
  • Português
  • Sinugboanong Binisaya
  • Svenska
  • Українська
  • Tiếng Việt
  • Winaray
  • 中文
  • Русский
Sunting pranala
url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url url
Pusat Layanan

UNIVERSITAS TEKNOKRAT INDONESIA | ASEAN's Best Private University
Jl. ZA. Pagar Alam No.9 -11, Labuhan Ratu, Kec. Kedaton, Kota Bandar Lampung, Lampung 35132
Phone: (0721) 702022
Email: pmb@teknokrat.ac.id